
NYSEHealthcareMedical - Devices
最新数据
US$362.62
−US$3.54 · -0.97%
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
常规交易时段
US$362.62
−US$3.54 · -0.97%
盘中时间采用ET。市场数据可能有所延迟。
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
日内区间
当前US$362.62
52周区间
当前US$362.62
盘中时间采用ET。市场数据可能有所延迟。
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
日内区间
当前US$362.62
52周区间
当前US$362.62
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 25.83亿 USD | 25.67亿 USD | 26.71亿 USD | 28.02亿 USD | 29.23亿 USD |
| 销货成本 | 12.4亿 USD | 11.88亿 USD | 12.44亿 USD | 12.35亿 USD | 12.84亿 USD |
| 毛利 | 13.44亿 USD | 13.79亿 USD | 14.27亿 USD | 15.67亿 USD | 16.38亿 USD |
| 研究与开发 | 2.57亿 USD | 2.96亿 USD | 2.47亿 USD | 2.57亿 USD | 2.61亿 USD |
| 销售、一般及管理费用 | 8.2亿 USD | 8.14亿 USD | 8.42亿 USD | 8.28亿 USD | 8.77亿 USD |
| 营业费用 | 10.78亿 USD | 11.1亿 USD | 10.89亿 USD | 10.85亿 USD | 11.38亿 USD |
| 利息收入 | 9550万 USD | 8200万 USD | 1.01亿 USD | 5800万 USD | 1890万 USD |
| 利息支出 | 4900万 USD | 4890万 USD | 4943.9万 USD | 3811.4万 USD | 155.1万 USD |
| 折旧和摊销 | 1.65亿 USD | 1.52亿 USD | 1.46亿 USD | 1.37亿 USD | 1.38亿 USD |
| 营业利润 | 2.71亿 USD | 2.69亿 USD | 3.38亿 USD | 4.83亿 USD | 5亿 USD |
| 净利润 | 7.6亿 USD | −18.44亿 USD | −6.37亿 USD | −36.28亿 USD | 42.54亿 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$350
下跌空间 3.48%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2002年3月8日 | 2:1 | — | — |
股票拆分 | 1996年6月3日 | 3:2 | — | — |
股票拆分 | 1986年6月11日 | 3:2 | — | — |
股票拆分 | 1985年8月1日 | 3:2 | — | — |
股票拆分 | 1980年3月18日 | 2:1 | — | — |
已生效 2002年3月8日
2:1
已生效 1996年6月3日
3:2
已生效 1986年6月11日
3:2
已生效 1985年8月1日
3:2
已生效 1980年3月18日
2:1
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2.26亿0.01%2.3万亿 USD0.03%US$381.75-0.05%
Vanguard Morningstar Small-Cap ETFVB1.64亿0.09%1853亿 USD0.03%US$288.94-0.19%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1.48亿0.55%268.09亿 USD0.33%US$38.05+0.26%
Vanguard Morningstar Small-Cap Value ETFVBR1.04亿0.15%682亿 USD0.05%US$234.76+0.14%
Vanguard Extended Market ETFVXF8086.4万0.08%954亿 USD0.05%US$234.27-0.31%
Dimensional - US Small Cap ETFDFAS5290.85万0.16%338.69亿 USD0.31%US$78.35-0.01%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY4920.23万0.19%258.17亿 USD0.23%US$669.5-0.06%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD3511.81万0.19%182.7亿 USD0.03%US$64.275-0.09%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
State Street SPDR S&P MIDCAP 400 ETF TrustMDY
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMDAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。